Search Results - "Eichenlaub, M"

Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONET by Fähndrich, S, Herr, C, Teuteberg, S, Alter, P, Söhler, S, Soriano, D, Classen, J, Adams, J, Weinhold, V, Watz, H, Waschki, B, Zeller, T, Eichenlaub, M, Trudzinski, F C, Michels, J D, Omlor, A, Seiler, F, Moneke, I, Biertz, F, Stolz, D, Welte, T, Kauczor, H U, Kahnert, K, Jörres, R A, Vogelmeier, C F, Bals, R

“…MRproANP and COPAVP are prognostic markers for mortality in chronic obstructive pulmonary disease (COPD). Furthermore, these biomarkers predict mortality due…”
Get full text

Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort by Frantzi, N, Nguyen, X P, Herr, C, Alter, P, Söhler, S, Soriano, D, Watz, H, Waschki, B, Trinkmann, F, Eichenlaub, M, Trudzinski, F C, Michels-Zetsche, J D, Omlor, A, Seiler, F, Moneke, I, Biertz, F, Rohde, G, Stolz, D, Welte, T, Kauczor, H U, Kahnert, K, Jörres, R A, Vogelmeier, C F, Bals, R, Fähndrich, S

“…The evidence regarding effects of statins on exacerbation risk in COPD remains controversial. Previous studies often excluded patients with cardiovascular…”
Get full text

The patient with dementia, the caregiver and the doctor: cognition, depression and quality of life from three perspectives by Arlt, Sönke, Hornung, Juliane, Eichenlaub, M., Jahn, Holger, Bullinger, Monika, Petersen, Corinna

“…Background For comprehensive information about the situation of patients with dementia or mild cognitive impairment (MCI), clinicians have to rely on…”
Get full text

A Glucose-Only Model to Extract Physiological Information from Postprandial Glucose Profiles in Subjects with Normal Glucose Tolerance by Eichenlaub, Manuel M., Khovanova, Natasha A., Gannon, Mary C., Nuttall, Frank Q., Hattersley, John G.

“…Background: Current mathematical models of postprandial glucose metabolism in people with normal and impaired glucose tolerance rely on insulin measurements…”
Get full text

Bayesian parameter estimation in the oral minimal model of glucose dynamics from non-fasting conditions using a new function of glucose appearance by Eichenlaub, Manuel M., Hattersley, John G., Gannon, Mary C., Nuttall, Frank Q., Khovanova, Natasha A.

“…•Bayesian parameter estimation in the oral minimal model of glucose dynamics.•Identification from non-fasting conditions.•Introduction of a novel function…”
Get full text

MIS instruments : An experimental comparison of various ergonomic handles and their design by MATERN, U, EICHENLAUB, M, WALLER, P, RÜCKAUER, K.-D

“…Various handles are available for use in minimally invasive surgery. Nonergonomic positioning of the hand and fingers can lead to pressure areas, nerve…”
Get full text

Predictive value of late gadolinium enhancement MRI in patients with persistent atrial fibrillation. Multicentric validation of a standardised method by Althoff, T F, Eichenlaub, M, Padilla, D, Brugada, J, Arentz, T, Mont, L, Jadidi, A

“…Abstract Background With recurrence rates after PVI in persistent atrial fibrillation (AF) as high as 50%, predictive tools to improve patient selection are…”
Get full text

P13-29 A new mutagenicity NAM: An in vitro Transgenic Rodent (TGR) assay for the detection of mutagens and assessment of their mechanism of action by Funk-Weyer, D., Landsiedel, R., Göpfert, A., Rülker, C., Eichenlaub, M., Tokovenko, B., Honarvar, N., Schuster, D.

Get full text

Expression of xenobiotic transporters in the rat and rabbit kidney, liver and placenta during pre- and postnatal development by Weyrich, A., Frericks, M., Hofmann, T., Schneider, S., Eichenlaub, M., van Ravenzwaay, B.

Get full text

Characterization of the circumferential cevel of the pulmonary vein isolation area using pulsed-field catheter ablation: Spatial distribution and extent of insufficient and excessive isolation areas by Bohnen, M, Weber, R, Eichenlaub, M, Jadidi, A, Neumann, FJ, Arentz, T, Lehrmann, H

“…Abstract Funding Acknowledgements Type of funding sources: None. Introduction The cornerstone of pulmonary vein isolation (PVI) is a wide area circumferential…”
Get full text

Analysis of the Amplified P-Wave or Artificial Intelligence-Derived P-wave-Analysis Enable Identification of Patients with Atrial Fibrillation during Sinus Rhythm by Jadidi, A, Huang, T, Pilia, N, Mueller-Edenborn, B, Eichenlaub, M, Allgeier, J, Trenk, D, Westermann, D, Arentz, T

“…Abstract Funding Acknowledgements Type of funding sources: None. Introduction / Aims This study sought to develop and validate diagnostic models to identify…”
Get full text

Pulmonary vein isolation and additional selective ablation of low voltage areas and atrial late potentials for persistent atrial fibrillation (SOLVE-AF-Study) by Jadidi, A, Mueller-Edenborn, B, Eichenlaub, M, Lehrmann, H, Allgeier, J, Trenk, D, Neumann, F, Westermann, D, Arentz, T

“…Abstract Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Abbott Introduction Novel catheter ablation technologies…”
Get full text

Identifying ablation targets using regional voltage thresholds in atrial fibrillation patients by Eichenlaub, M, Nairn, D, Nagel, C, Mueller-Edenborn, B, Lehrmann, H, Arentz, T, Doessel, O, Jadidi, A, Loewe, A

“…Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): We gratefully acknowledge financial…”
Get full text

Comparison between Novel and Conventional Electrocardiographic Markers of Atrial Cardiomyopathy for identification of Persons at Risk for Ischemic Stroke by Huang, T, Aldaoud, S A, Mueller-Edendorn, B M E, Pilia, N P, Eichenlaub, M E, Allgeier, J A, Keyl, C K, Neumann, F J N, Trenk, D T, Westermann, D W, Arentz, T A, Jadidi, A J

“…Abstract Background Atrial cardiomyopathy is associated with increased risk for future atrial fibrillation (AF) and ischemic stroke. Several ECG-derived…”
Get full text

Machine learning for development of ECG-based prediction models for atrial fibrillation, thromboembolism and mortality in patients with heart failure by Huang, T H, Ahlgrim, C A, Mueller-Edendorn, B M E, Pilia, N P, Eichenlaub, M E, Allgeier, J A, Keyl, C K, Neumann, F J N, Trenk, D T, Westermann, D W, Arentz, T A, Jadidi, A J

“…Abstract Background Heart failure (HF) is a worldwide epidemic affecting more than 64 million people. Given its massive burden both socially and economically,…”
Get full text

Comparison of various late gadolinium enhancement magnetic resonance imaging methods to high-definition voltage and activation mapping for detection of atrial cardiomyopathy by Eichenlaub, M, Mueller-Edenborn, B, Minners, J, Hein, M, Ruile, P, Lehrmann, H, Schoechlin, S, Allgeier, J, Bohnen, M, Trenk, D, Neumann, F-J, Arentz, T, Jadidi, A

“…Abstract Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Medtronic Background/Introduction Atrial cardiomyopathy…”
Get full text

Comparison of various tools for diagnosis of an atrial cardiomyopathy for outcome prediction after pulmonary vein isolation in patients with persistent atrial fibrillation - What is the Holy Grail? by Eichenlaub, M, Lehrmann, H, Minners, J, Schoechlin, S, Mueller-Edenborn, B, Jander, N, Allgeier, M, Allgeier, J, Bohnen, M, Neumann, F J, Trenk, D, Westermann, D, Arentz, T, Jadidi, A

“…Abstract Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Medtronic Background Atrial cardiomyopathy (ACM) is…”
Get full text

55Non-invasive ECG-imaging for identification of atrial arrhythmogenic low voltage substrate in patients with persistent atrial fibrillation by Eichenlaub, M, Lehrmann, H, Mueller-Edenborn, B, Allgeier, J, Weber, R, Trenk, D, Neumann, F-J, Arentz, T, Jadidi, A

“…Abstract Background/Introduction Left atrial (LA) fibrosis is associated with increased arrhythmia recurrence rates after pulmonary vein isolation (PVI) and…”
Get full text

P6551Evaluation of a new ultra low-dose radiation protocol during electrophysiological device implantation by Eichenlaub, M, Astheimer, K, Restle, C, Maring, C, Blum, T, Minners, J, Schweitzer, S, Thiel, U, Neumann, F.-J, Arentz, T, Lehrmann, H

“…Abstract Objectives The aim of this study was to evaluate the impact of a new ultra low-dose radiation protocol on radiation doses, feasibility and safety…”
Get full text

Midregional proatrial naturetic peptide as predictors of all-cause mortality in recently diagnosed mild to moderate COPD--results from COSYCONET by Fähndrich, S, Herr, C, Teuteberg, S, Alter, P, Söhler, S, Soriano, D, Classen, J, Adams, J, Weinhold, V, Watz, H, Waschki, B, Zeller, T, Eichenlaub, M, Trudzinski, F. C, Michels, J. D, Omlor, A, Seiler, F, Moneke, I, Biertz, F, Stolz, D, Welte, T, Kauczor, H. U, Kahnert, K, Jörres, R. A, Vogelmeier, C. F, Bals, R, Andreas, Stefan, Alter, Peter, Bals, Robert, Behr, Jürgen, Kahnert, Kathrin, Bahmer, Thomas, Bewig, Burkhard, Ewert, Ralf, Stubbe, Beate, Ficker, Joachim H, Grohé, Christian, Held, Matthias, Henke, Markus, Herth, Felix, Kirsten, Anne-Marie, Watz, Henrik, Koczulla, Rembert, Kronsbein, Juliane, Kropf-Sanchen, Cornelia, Herzmann, Christian, Pfeifer, Michael, Randerath, Winfried J, Seeger, Werner, Studnicka, Michael, Taube, Christian, Timmermann, Hartmut, Schmeck, Bernd, Vogelmeier, Claus, Welte, Tobias, Wirtz, Hubert

“…Background MRproANP and COPAVP are prognostic markers for mortality in chronic obstructive pulmonary disease (COPD). Furthermore, these biomarkers predict…”
Get full text